An HDF panel, short for Hemoglobinopathy Differential panel, is a group of blood tests designed to identify abnormal types of hemoglobin in your blood. Hemoglobin is the protein inside red blood cells that carries oxygen throughout your body. The panel screens for inherited blood disorders like sickle cell disease and thalassemia by measuring the different forms of hemoglobin present and flagging any variants that could cause health problems.
What the Panel Measures
Your blood contains several types of hemoglobin, and the HDF panel breaks down exactly how much of each type you have. In a healthy adult, normal hemoglobin (called HbA) makes up 95% to 98% of the total. A smaller fraction called HbA2 accounts for 2% to 3%, and fetal hemoglobin (HbF) typically sits between 0.8% and 2%. Newborns are different: fetal hemoglobin makes up 50% to 80% of their total, which gradually decreases over the first year of life.
The panel specifically looks for variant hemoglobins, including HbS (the form linked to sickle cell disease), HbC, HbD, and HbE. If any of these show up, the lab measures how much is present. Higher-than-normal levels of HbA2 or HbF can also point toward thalassemia, even when no unusual variants are detected. The final component is an interpretation from a pathologist who reviews the full picture and provides a clinical assessment.
Conditions the Panel Detects
The HDF panel is primarily used to diagnose or rule out two major categories of inherited blood disorders: sickle cell disease and thalassemia.
Sickle cell disease occurs when a person inherits two copies of abnormal hemoglobin genes. The most common form involves two copies of HbS, but compound combinations like HbSC, HbSD, or HbS paired with beta-thalassemia also cause the disease. People with just one copy of HbS are carriers (sickle cell trait) and typically don’t have symptoms, but the panel identifies them so they can make informed decisions about family planning.
Thalassemia involves reduced production of one of the protein chains that make up hemoglobin. In beta-thalassemia trait, HbA2 levels are elevated above 3.5%. In alpha-thalassemia, HbA2 tends to be low to low-normal, in the range of 1.5% to 2.5%. This distinction matters because the two forms carry different genetic risks and require different follow-up. The panel can also pick up less common hemoglobin variants that cause unexplained anemia or other blood abnormalities.
When Doctors Order It
There are several situations where you might be asked to take this test. The most common include:
- Prenatal screening: The American College of Obstetricians and Gynecologists recommends offering universal hemoglobinopathy testing to anyone planning a pregnancy or at the first prenatal visit, if no prior results are available. This replaced older guidelines that screened based on race or ethnicity.
- Newborn screening: Most states screen newborns for common hemoglobinopathies like HbS and HbC shortly after birth.
- Unexplained anemia: If blood work shows small, pale red blood cells (microcytic anemia) and iron deficiency has been ruled out, the panel helps determine whether thalassemia is the cause.
- Family history: If a close relative carries a hemoglobin variant or has been diagnosed with a hemoglobin disorder.
- Unexplained symptoms: Cyanosis (bluish skin) despite adequate oxygen levels, or an unexplained increase in red blood cell count, can both prompt the test.
If both parents are found to be carriers of a hemoglobin variant, genetic counseling helps them understand the odds of their child inheriting the full disease and what reproductive options are available, including preimplantation genetic testing and prenatal diagnosis.
How the Testing Works
The HDF panel uses a combination of lab techniques to identify and measure hemoglobin types. Two methods do most of the heavy lifting.
The first is hemoglobin electrophoresis, specifically a technique called isoelectric focusing. This separates hemoglobin molecules based on their electrical charge. Different hemoglobin types migrate to different positions on a gel, creating a visual pattern the lab can read. It reliably separates HbC from HbE and HbS from HbD, which look identical on older electrophoresis methods.
The second is high-performance liquid chromatography, or HPLC. This automated technique pushes a blood sample through a column that separates hemoglobin types by how strongly they bind to the column material. HPLC can detect and measure a wide range of hemoglobins, including HbA, HbA2, HbF, HbS, HbC, HbD-Punjab, and HbO-Arab, making it more comprehensive than electrophoresis alone. It has become the preferred method for initial screening and is particularly useful for accurately measuring the small percentages of HbA2 and HbF that help diagnose thalassemia.
One limitation worth knowing: in people who carry HbS, HPLC can slightly overestimate HbA2 levels. When this happens, the lab may use a third technique called capillary zone electrophoresis to get a more accurate reading. Using multiple methods together is what makes the panel reliable, since each technique compensates for the blind spots of the others.
What to Expect as a Patient
The HDF panel requires a standard blood draw, typically from a vein in your arm. No fasting is required for hemoglobin testing, though you should mention any medications, vitamins, or supplements you’re taking, as some can potentially affect results. Recent blood transfusions can also interfere with accuracy, since transfused blood introduces donor hemoglobin into the sample.
Results typically take several days because the panel involves multiple lab techniques and requires pathologist interpretation. Your report will list the percentages of each hemoglobin type detected, along with a written interpretation that explains whether the findings are normal, consistent with a carrier state, or suggestive of a hemoglobin disorder. If a variant is found, your doctor may recommend testing for family members or refer you to a hematologist or genetic counselor for further evaluation.
Reading Your Results
A normal adult result shows HbA at 95% to 98%, HbA2 at 2% to 3%, HbF below 2%, and no variant hemoglobins detected. Deviations from these ranges point toward specific conditions.
An HbA2 level above 3.5% with slightly low HbA is the hallmark of beta-thalassemia trait. An HbA2 in the low-normal range (1.5% to 2.5%) with small red blood cells may suggest alpha-thalassemia, though confirming alpha-thalassemia often requires genetic (DNA) testing since the hemoglobin pattern can look nearly normal.
If HbS is present at roughly 35% to 45% with the rest being HbA, that indicates sickle cell trait, a carrier state. If HbS makes up 80% or more with no HbA detected, that points to sickle cell disease. Combinations like HbS plus HbC, each around 45% to 50%, indicate HbSC disease, a form of sickle cell disease with its own clinical profile. Elevated HbF in an adult, particularly above 5% to 10%, can suggest certain forms of thalassemia or a hereditary condition called hereditary persistence of fetal hemoglobin, which is generally benign.